RT Journal Article
SR Electronic
T1 Alarming downtrend in mechanical thrombectomy rates in African American patients during the COVID-19 pandemic-Insights from STAR
JF Journal of NeuroInterventional Surgery
JO J NeuroIntervent Surg
FD BMJ Publishing Group Ltd.
SP 304
OP 307
DO 10.1136/neurintsurg-2020-016946
VO 13
IS 4
A1 Al Kasab, Sami
A1 Almallouhi, Eyad
A1 Alawieh, Ali
A1 Jabbour, Pascal
A1 Sweid, Ahmad
A1 Starke, Robert M
A1 Saini, Vasu
A1 Wolfe, Stacey Q
A1 Fargen, Kyle M
A1 Arthur, Adam S
A1 Goyal, Nitin
A1 Pandhi, Abhi
A1 Maier, Ilko
A1 Grossberg, Jonathan A
A1 Howard, Brian M
A1 Tjoumakaris, Stavropoula I
A1 Rai, Ansaar
A1 Park, Min S
A1 Mascitelli, Justin R
A1 Psychogios, Marios N
A1 Spiotta, Alejandro M
YR 2021
UL http://jnis.bmj.com/content/13/4/304.abstract
AB Background The coronavirus disease (COVID-19) pandemic has affected stroke care globally. In this study, we aim to evaluate the impact of the current pandemic on racial disparities among stroke patients receiving mechanical thrombectomy (MT).Methods We used the prospectively collected data in the Stroke Thrombectomy and Aneurysm Registry from 12 thrombectomy-capable stroke centers in the US and Europe. We included acute stroke patients who underwent MT between January 2017 and May 2020. We compared baseline features, vascular risk factors, location of occlusion, procedural metrics, complications, and discharge outcomes between patients presenting before (before February 2020) and those who presented during the pandemic (February to May 2020).Results We identified 2083 stroke patients: of those 235 (11.3%) underwent MT during the COVID-19 pandemic. Compared with pre-pandemic, stroke patients who received MT during the pandemic had longer procedure duration (44 vs 38 min, P=0.006), longer length of hospitalization (6 vs 4 days, P<0.001), and higher in-hospital mortality (18.7% vs 11%, P<0.001). Importantly, there was a lower number of African American patients undergoing MT during the COVID-19 pandemic (609 (32.9%) vs 56 (23.8%); P=0.004).Conclusion The COVID-19 pandemic has affected the care process for stroke patients receiving MT globally. There is a significant decline in the number of African American patients receiving MT, which mandates further investigation.